Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort-Reference-Cited by-同舟云学术

Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort

Published:2018-01-03 Issue:2 Volume:19 Page:147-156
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Shahabi Payman,Lamothe Félix,Dumas Stéphanie,Rouleau-Mailloux Étienne,Feroz Zada Yassamin,Provost Sylvie,Asselin Geraldine,Mongrain Ian,Valois Diane,Gaulin Marion Marie-Josée,Lemieux Perreault Louis-Philippe,Perreault Sylvie,Dubé Marie-Pierre^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/s41397-017-0005-1.pdf

Reference55 articles.

1. Johnson JA, Cavallari LH. Warfarin pharmacogenetics. Trends Cardiovasc Med. 2015;25:33–41.

2. Merli GJ, Tzanis G. Warfarin: what are the clinical implications of an out-of-range-therapeutic international normalized ratio? J Thromb Thrombolys. 2009;27:293–9.

3. Carnes CA. What is the role of pharmacogenetics in optimization of warfarin dosing? Trends Cardiovasc Med. 2015;25:42–3.

4. Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e44S–e88S.

5. Wadelius M, Pirmohamed M. Pharmacogenetics of warfarin: current status and future challenges. Pharm J. 2007;7:99–111.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety Issues of Herb-Warfarin Interactions;Current Drug Metabolism;2024-01

2. The cytotoxic potential of sinapic acid on luminal A breast cancer; a computational and experimental pharmacology approach;Journal of Biomolecular Structure and Dynamics;2023-10-30

3. Genotype‐guided warfarin therapy: Still of only questionable value two decades on;Journal of Clinical Pharmacy and Therapeutics;2020-03-13

4. Cardiovascular Pharmacogenomics: Does It Matter If You're Black or White?;Annual Review of Pharmacology and Toxicology;2019-01-06

5. ASSOCIATION BETWEEN FOUR MICRORNA BINDING SITE-RELATED POLYMORPHISMS AND THE RISK OF WARFARIN-INDUCED BLEEDING COMPLICATIONS;EXCLI J;2019